HARROW, INC. (HROWL)

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Address

102 WOODMONT BLVD
NASHVILLE, TN 37215

Founded

2006

Number of Employees

315

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)